News from the BioRN Cluster

Home  >>  News from the BioRN Cluster

New member: Welcome in our cluster to Efficient Robotics

On February 20, 2019, Posted by , In News, By , With Comments Off on New member: Welcome in our cluster to Efficient Robotics

We are happy to welcome in our cluster Efficient Robotics:     Founded in 2012, Efficient Robotics is evolving into a leading company for the development and commercialization of microfluidic systems for the pharmaceutical, biotechnology and chemical industry. The technology of Efficient Robotics GmbH enables the miniaturization of complex biological…

Official start of a new research center for individualized cancer immunotherapy: the Helmholtz Institute for Translational Oncology (HI-TRON)

On February 19, 2019, Posted by , In News, By ,, , With Comments Off on Official start of a new research center for individualized cancer immunotherapy: the Helmholtz Institute for Translational Oncology (HI-TRON)

The new Helmholtz Institute for Translational Oncology (HI-TRON Mainz) aims to develop into one of the world’s leading centres for personalised cancer immunotherapy. This is the ambitious goal of the cooperation partners German Cancer Research Center (DKFZ) and Research Institute for Translational Oncology (TRON gGmbH) at the Johannes Gutenberg University…

Opening of the first Fraunhofer Project Center in Israel

On February 19, 2019, Posted by , In News, By , , With Comments Off on Opening of the first Fraunhofer Project Center in Israel

Fraunhofer has been working successfully with research partners in Israel for almost ten years. This cooperation is now being further expanded. The first two Fraunhofer Project Centers at the Hebrew University of Jerusalem in Israel will be open in April Fraunhofer Project Center for Drug Discovery and Delivery – as…

Working together towards new objectives and activities in the Life Science Rhine/Main/Neckar Region.

On February 15, 2019, Posted by , In Press Releases, With Comments Off on Working together towards new objectives and activities in the Life Science Rhine/Main/Neckar Region.

Heidelberg, 15.02.2019 How can BioRN better support the regional life science ecosystem? How can existing opportunities be leveraged and weaknesses be overcome? How can regional stakeholders better work together to reach our common goal – turning the region in one of the world leading life science clusters worldwide? These and…

EMBL – Role reversal: RNA controls protein function

On February 15, 2019, Posted by , In News, By , With Comments Off on EMBL – Role reversal: RNA controls protein function

Strands of RNA can bind to proteins to prevent the cell from carrying out autophagy – ‘self-eating’. IMAGE: Tobias Wüstefeld EMBL scientists identify RNA regulating protein behaviour in switch of normal roles Ribonucleic acids (RNAs) perform many important roles within cells, mainly ensuring that proteins are made in the right…

KIT: Artificial Intelligence in Medicine

On February 15, 2019, Posted by , In News, By , , With Comments Off on KIT: Artificial Intelligence in Medicine

A new BMBF funded project analyzes opportunities and challenges of Artificial Intelligence, modern human genomics and genome editing.   Treating diseases, “improving” the genetic make-up: Researchers at KIT are investigating what AI can contribute here and what ethical questions it raises (Picture: Pixabay)   Deciphering the human genome is still…

Merck and BioMed X expand collaboration to immunology research

On February 15, 2019, Posted by , In News, By , , With Comments Off on Merck and BioMed X expand collaboration to immunology research

Heidelberg, Germany, February 14th, 2019 – BioMed X announced today to add a further research program to the collaboration with Merck. In accordance with the provisions of the existing contract, a new crowdsourcing project will be launched in the field of autoimmune diseases. BioMed X and Merck started their partnership…

DKFZ: The development of brain stem cells into new nerve cells and why this can lead to cancer

On February 6, 2019, Posted by , In News, By , , With Comments Off on DKFZ: The development of brain stem cells into new nerve cells and why this can lead to cancer

Stem cells are true “Jacks-of-all-trades” of our bodies, as they can turn into the many different cell types of all organs. This allows the tissues such as muscle or even brain to renew and to heal after injury. This amazing “multipotency” makes stem cells in the adult body key tools…

Learning from the best part 2: Nurturing the BioRN regional startup ecosystem.

On February 5, 2019, Posted by , In Press Releases, By , With Comments Off on Learning from the best part 2: Nurturing the BioRN regional startup ecosystem.

Heidelberg, 01.02.2019 In its visionary mission, BioRN aims to develop the region into a world-leading life science cluster, by nurturing the regional startup ecosystem, attract global investments and talents. Within its new strategy, BioRN propose as potential instrument to enable this process the conception of an incubator in Heidelberg. A…

DKFZ – ERC grant for Stefan Pfister: “We must further advance pediatric cancer research”

On January 29, 2019, Posted by , In News, By , , With Comments Off on DKFZ – ERC grant for Stefan Pfister: “We must further advance pediatric cancer research”

KiTZ director Stefan Pfister, professor of pediatric neurooncology at the German Cancer Research Center (DKFZ) and the Heidelberg University Hospital, succeeded in gaining one of the prestigious ERC Consolidator Grants for his project entitled “BRAIN-MATCH”. The goal of BRAIN-MATCH is to characterize normal brain development using molecular-biological methods and to…

NEC provides a digital scanner to the Heidelberg University Hospital to accelerate joint research on cancer treatment

On January 28, 2019, Posted by , In News, By , , With Comments Off on NEC provides a digital scanner to the Heidelberg University Hospital to accelerate joint research on cancer treatment

NEC Laboratories Europe GmbH (NEC) provided a very high-resolution digital scanner to the Department of Applied Tumor Biology at the Institute of Pathology of the Heidelberg University Hospital for digitizing images of cancer tissue samples. The Heidelberg scientists Prof. Dr. Magnus of Knebel Doeberitz and Dr. Matthias Kloor with Motoo…

Learning from the best: how to accelerate academic research to the clinic.

On January 25, 2019, Posted by , In Press Releases, By , With Comments Off on Learning from the best: how to accelerate academic research to the clinic.

Heidelberg, 25.01.2019 Within its new strategy, BioRN led special attention on the improvement of the academic translational potential and in leveraging the unique combination of global pharma and leading innovators in the network. BioRN executive and strategic boards created a working group with a specific focus on accelerating academic research…

DKFZ: A major step towards digital oncology

On January 24, 2019, Posted by , In News, By , , With Comments Off on DKFZ: A major step towards digital oncology

Methods of artificial intelligence (AI) such as deep learning using neural networks are gaining increasing importance in health research and personalized medicine. In oncology, new experimental and diagnostic methods such as genome sequencing and whole-body imaging by magnetic resonance imaging are also generating growing amounts of data. © Fotolia Using…

HITS: The state-of-the-art of ‘Molecular Modeling in Drug Design’

On January 23, 2019, Posted by , In News, By , With Comments Off on HITS: The state-of-the-art of ‘Molecular Modeling in Drug Design’

New Special Issue in the journal ‘Molecules’ out on the state-of-the-art of ‘Molecular Modeling in Drug Design’ guest edited by Rebecca Wade (HITS) and Outi Salo-Ahen (Abo Akademi University, Turku, Finland) This Special Issue contains thirteen articles that provide a vivid snapshot of the state-of-the-art of molecular modeling in drug…

DKFZ-Vaccination as a therapy: Experimental vaccine against cervical cancer successfully tested in mice

On January 23, 2019, Posted by , In News, By , , With Comments Off on DKFZ-Vaccination as a therapy: Experimental vaccine against cervical cancer successfully tested in mice

Scientists from the German Cancer Research Center (DKFZ) have developed an experimental vaccine to fight cervical cancer caused by human papillomaviruses (HPV). This has already been accomplished successfully in mice. Tumors regressed in half of the vaccinated animals. The scientists’ goal is to develop a therapeutic vaccine for people who…

EVI: First clinical results for a vaccine against placental malaria

On January 23, 2019, Posted by , In News, With Comments Off on EVI: First clinical results for a vaccine against placental malaria

EVI-supported project publishes first clinical results for vaccine candidate to prevent pregnancy-associated malaria. First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria. For full article, please follow the link.  

Miltenyi Biotec joins EMBL’s Corporate Partnership Programme

On January 18, 2019, Posted by , In News, By , , With Comments Off on Miltenyi Biotec joins EMBL’s Corporate Partnership Programme

Joining forces to advance training in biomedical research and therapy EMBL and Miltenyi Biotec, a global provider of products and services that advance biomedical research and cellular therapy from basic and translational research to clinical application, have teamed up in the EMBL Advanced Training Centre Corporate Partnership Programme to advance research…

BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases

On January 18, 2019, Posted by , In News, By , , With Comments Off on BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases

Heidelberg, Germany, January 17th, 2019 – BioMed X announced a new crowdsourcing project within its framework collaboration with Boehringer Ingelheim. BioMed X and Boehringer Ingelheim started their partnership in 2014 and since then have initiated three preclinical research projects in the fields of respiratory diseases, neuroscience and immunology. The new…

“Life Time” – European research for a healthier future

On January 15, 2019, Posted by , In News, By , , With Comments Off on “Life Time” – European research for a healthier future

Our body’s cells are constantly changing. But which of these changes are healthy developments and which lead to serious diseases? This is what LifeTime, a new transnational and interdisciplinary initiative of leading European researchers, aims to discover. The consortium is jointly coordinated by the Max Delbrück Center in Berlin and…

AbbVie: towards innovative therapies with “Alfons”

On January 15, 2019, Posted by , In News, By , , With Comments Off on AbbVie: towards innovative therapies with “Alfons”

What does the future of research actually look like? Alfons” gives an answer to this question. What sounds like a first name that has gone out of fashion stands for the finest in high technology. “Automated Liquid Formulation Screening” is a real innovation: Using the data generated with this system,…